A PYMNTS Company

Spain: In Pharmacy report, CNMC calls for removing entry barriers

By  |  October 27, 2015

Spain’s National Markets and Competition Commission has published a Study on the Retail Distribution of Medicine in Spain, where they analyze the various restrictions on competition that plague this market. The study concludes with a series of recommendations to improve efficiency in this sector.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The study finds that Spain’s current legislation imposes several restrictions on accessing, owning and maintaining a business in the drug retail market, causing a negative impact on competition and harming consumers.

    The CNMC has, therefore, recommended the elimination of these restrictions on accessing the market: namely, the obligatory minimum distances between pharmacies and health providers; the elimination on restrictions on trading hours and advertising, and easing the requirements for opening a new pharmacy, among others.

    Source: CNMC

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.